Jiayao Lei is awarded the Dimitris N. Chorafas Prize 2020
Jiayao Lei is awarded The Dimitris N. Chorafas Prize 2020. The Prize (USD 5.000) is meant to reward pre-graduate scientific contributions within the doctoral education. She will receive the prize at the Installation Ceremony on October 15, 2020.
Jiayao Lei is awarded the prize for her thesis "Prevention and prognosis of cervical cancer: the interplay of human papillomavirus, vaccination and screening"
Cervical cancer has become preventable since the introduction of cervical screening. Human papillomavirus (HPV) vaccines, together with new screening tests provides the potential to eliminate cervical cancer as a public health problem. In order to achieve this goal, further understanding of the role of HPV, effectiveness of cervical screening and HPV vaccination as well as pragmatic change of current practices are needed. Jiayao Lei’s research addresses the relevant questions from current practice and serves as evidence base for future policy changes towards elimination of cervical cancer.
Jiayao’s research has mainly focused on comprehensive evaluation of HPV vaccination and cervical screening using nationwide Swedish registers. Additionally, her research also lies on understanding the role of HPV in prognosis of cervical cancer integrating biobank data.
Her current research has impacted women’s health both in Sweden and internationally. She is determined to continue her work in improving public health and clinical practices through evidence-based research.
Jiayao Lei conducted doctoral research at the Department of Medical Epidemiology and Biostatistics under the supervision of Pär Sparén, Miriam Elfström, Joakim Dillner and Fang Fang.
Prize motivation:
"Jiayao Lei is an exceptional student who has produced an outstanding thesis. Her research has mainly focused on comprehensive evaluation of HPV vaccination and cervical screening using nationwide Swedish registers. Additionally, her research has also focused on understanding the role of HPV in prognosis of cervical cancer through integrating biobank data."